Cargando…
Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells
BACKGROUND: The cytotoxicity of NK cells is largely dependent on IgG Fc receptor CD16a, which mediates antibody-dependent cell-mediated cytotoxicity (ADCC). The high-affinity and non-cleavable CD16 (hnCD16) is developed and demonstrated a multi-tumor killing potential. However, the hnCD16 receptor a...
Autores principales: | Meng, Fanyi, Zhang, Siqi, Xie, Juan, Zhou, Yuan, Wu, Qingling, Lu, Binyan, Zhou, Shixin, Zhao, Xiangyu, Li, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265820/ https://www.ncbi.nlm.nih.gov/pubmed/37316891 http://dx.doi.org/10.1186/s13045-023-01455-z |
Ejemplares similares
-
Leveraging iPSC technology to assess neuro-immune interactions in neurological and psychiatric disorders
por: Michalski, Christina, et al.
Publicado: (2023) -
iPSC-Derived Natural Killer Cells for Cancer Immunotherapy
por: Karagiannis, Peter, et al.
Publicado: (2021) -
Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
por: Maddineni, Sainiteesh, et al.
Publicado: (2022) -
Correction: Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Publicado: (2022) -
Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
por: Cichocki, Frank, et al.
Publicado: (2023)